BofA analysts are removing Microsoft (MSFT) from the firm’s “US 1 List,” which represents a collection of the best investment ideas that are drawn from the universe of Buy-rated, U.S.-listed stocks covered by BofA Global Research fundamental equity research analysts. The firm is renewing Boston Scientific (BSX) and Spotify Technology (SPOT) for a new term following 52 weeks on the list.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MSFT:
- How Microsoft Stock (MSFT) Became Ensnared in Trump’s Tariff Headwinds
- Microsoft’s Strong Position in GenAI and Cloud Services Supports Buy Rating
- 3 Small to Large-Cap Stocks Poised for Long-Term Greatness
- Trump Tariffs Sound Alarm Across Magnificent Seven Stocks
- AI Daily: OpenAI considers buying Altman’s AI hardware startup